Matches in Wikidata for { <http://www.wikidata.org/entity/Q37639812> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- Q37639812 description "article científic" @default.
- Q37639812 description "article scientifique" @default.
- Q37639812 description "articolo scientifico" @default.
- Q37639812 description "artigo científico" @default.
- Q37639812 description "artículu científicu espublizáu en 2014" @default.
- Q37639812 description "bilimsel makale" @default.
- Q37639812 description "scientific article published on 25 February 2014" @default.
- Q37639812 description "vedecký článok" @default.
- Q37639812 description "vetenskaplig artikel" @default.
- Q37639812 description "videnskabelig artikel" @default.
- Q37639812 description "vědecký článek" @default.
- Q37639812 description "wetenschappelijk artikel" @default.
- Q37639812 description "wissenschaftlicher Artikel" @default.
- Q37639812 description "наукова стаття, опублікована в лютому 2014" @default.
- Q37639812 description "научни чланак" @default.
- Q37639812 description "مقالة علمية نشرت في 25 فبراير 2014" @default.
- Q37639812 name "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 name "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 name "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 type Item @default.
- Q37639812 label "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 label "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 label "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 prefLabel "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 prefLabel "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 prefLabel "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 P1433 Q37639812-BFD07660-D2DE-4559-894D-CC9F0C303015 @default.
- Q37639812 P1476 Q37639812-6B0565B9-D1DA-4FB0-975D-3055C3500CBB @default.
- Q37639812 P2093 Q37639812-41C9B0B0-60A9-42A0-B1A5-1B6AF5C859C6 @default.
- Q37639812 P2093 Q37639812-43835985-4085-464B-8705-068F8D20D5E1 @default.
- Q37639812 P2093 Q37639812-EC16FF99-BED5-43C0-ADF7-374B3AECE2D2 @default.
- Q37639812 P275 Q37639812-0D1264B6-B608-474F-870D-089655F97460 @default.
- Q37639812 P2860 Q37639812-005620CA-E8E4-49B5-AE61-7F7A11D74357 @default.
- Q37639812 P2860 Q37639812-1090568F-724D-4414-A7AD-4AC0D6BDD974 @default.
- Q37639812 P2860 Q37639812-13E51C58-8205-4D11-B5F8-C6BAD808F92F @default.
- Q37639812 P2860 Q37639812-28875B1F-3988-410E-9137-E409434A440E @default.
- Q37639812 P2860 Q37639812-2B4324A9-AAE6-4C50-AA63-42755704AB0F @default.
- Q37639812 P2860 Q37639812-57A78DD4-3FD4-4E44-86DA-65DABB04F70F @default.
- Q37639812 P2860 Q37639812-720BA329-595C-4216-A20D-20810BCDC1F1 @default.
- Q37639812 P2860 Q37639812-84E3927A-B8F5-472E-8F84-2BAA517B07A6 @default.
- Q37639812 P2860 Q37639812-9197DC0F-5B83-43CA-A0AB-58A5260220A6 @default.
- Q37639812 P2860 Q37639812-BB6C93F9-32D1-4F3D-9AE4-88DEF791A112 @default.
- Q37639812 P2860 Q37639812-BECDB8CE-9CD9-4BA0-AFAE-9BA360CF2EA1 @default.
- Q37639812 P2860 Q37639812-BF2EBF04-977B-499C-9B9A-052AD95770AE @default.
- Q37639812 P2860 Q37639812-DA7D85BE-26D4-4694-89EE-11C8527BE501 @default.
- Q37639812 P2860 Q37639812-E5CDE98E-F4B1-43CC-A44E-800AA7D39A96 @default.
- Q37639812 P2860 Q37639812-FF42013A-4A05-4B17-A37B-573B42789148 @default.
- Q37639812 P304 Q37639812-91BEB617-7A35-4D43-BCDF-926276BE8A9C @default.
- Q37639812 P31 Q37639812-E0AD69FF-6CA6-4C83-8864-F560DAC02CDA @default.
- Q37639812 P356 Q37639812-52AC8390-7A5A-405D-BE7F-C47C6E58AA3A @default.
- Q37639812 P407 Q37639812-CB814426-1962-4296-86AF-847AD22DA6B4 @default.
- Q37639812 P478 Q37639812-C4935BAD-8BDD-490B-B027-B635F139416B @default.
- Q37639812 P50 Q37639812-73E08B1B-69C9-4E2E-9369-D80456664ACC @default.
- Q37639812 P577 Q37639812-B0B3733C-1ABC-4AD1-B0EF-A18F4E207DED @default.
- Q37639812 P5875 Q37639812-5138A0CF-A761-42C3-AFCC-24A98E30F476 @default.
- Q37639812 P6216 Q37639812-9A5915DB-2E13-40FC-8F6F-B68F4D4B5260 @default.
- Q37639812 P698 Q37639812-A920CF55-DBCF-4D19-BC6E-0C9CEAD65672 @default.
- Q37639812 P921 Q37639812-838BC846-1EE6-4C16-89A0-0DDB45B52A8A @default.
- Q37639812 P932 Q37639812-EA835C3D-6865-4D29-846B-FAC64DCCFA80 @default.
- Q37639812 P356 151706 @default.
- Q37639812 P698 24719761 @default.
- Q37639812 P1433 Q26842036 @default.
- Q37639812 P1476 "Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting" @default.
- Q37639812 P2093 "Gary Oderda" @default.
- Q37639812 P2093 "Mallik Greene" @default.
- Q37639812 P2093 "Ning Wu" @default.
- Q37639812 P275 Q14947546 @default.
- Q37639812 P2860 Q34336740 @default.
- Q37639812 P2860 Q35919205 @default.
- Q37639812 P2860 Q36369778 @default.
- Q37639812 P2860 Q36623299 @default.
- Q37639812 P2860 Q37097601 @default.
- Q37639812 P2860 Q37514319 @default.
- Q37639812 P2860 Q37850217 @default.
- Q37639812 P2860 Q37855347 @default.
- Q37639812 P2860 Q43181662 @default.
- Q37639812 P2860 Q43575050 @default.
- Q37639812 P2860 Q47280311 @default.
- Q37639812 P2860 Q55043049 @default.
- Q37639812 P2860 Q80545862 @default.
- Q37639812 P2860 Q82121675 @default.
- Q37639812 P2860 Q84087603 @default.
- Q37639812 P304 "151706" @default.
- Q37639812 P31 Q13442814 @default.
- Q37639812 P356 "10.1155/2014/151706" @default.
- Q37639812 P407 Q1860 @default.
- Q37639812 P478 "2014" @default.
- Q37639812 P50 Q96250899 @default.
- Q37639812 P577 "2014-02-25T00:00:00Z" @default.
- Q37639812 P5875 "261521726" @default.
- Q37639812 P6216 Q50423863 @default.
- Q37639812 P698 "24719761" @default.
- Q37639812 P921 Q736715 @default.
- Q37639812 P932 "3955634" @default.